Evidence map›Paper›PMID 37238675›Full record

ArticleBiomolecules2023

Andreia Adrião, Sara Mariano, José Mariano, Paulo J Gavaia, M Leonor Cancela, Marta Vitorino, Natércia Conceição

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomolecules, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Andreia AdriãoCentre of Marine Sciences (CCMAR), Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, Portugal.
Sara MarianoCentre of Marine Sciences (CCMAR), Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, Portugal.
José MarianoFaculty of Sciences and Technology, Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, Portugal.ORCID 0000-0002-8480-617X
Paulo J GavaiaCentre of Marine Sciences (CCMAR), Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, Portugal.ORCID 0000-0002-9582-1957
M Leonor CancelaCentre of Marine Sciences (CCMAR), Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, Portugal.ORCID 0000-0003-3114-6662
Marta VitorinoCentre of Marine Sciences (CCMAR), Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, Portugal.
Natércia ConceiçãoCentre of Marine Sciences (CCMAR), Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, Portugal.ORCID 0000-0002-5057-0912
Algarve Biomedical Center · PTUniversity of Algarve · PTUniversity of Lisbon · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The transcription factor MEF2C is crucial in neuronal, cardiac, bone and cartilage molecular processes, as well as for craniofacial development. MEF2C was associated with the human disease MRD20, whose patients show abnormal neuronal and craniofacial development. Zebrafish

Indexed as

MEF2 Transcription FactorsZebrafishZebrafish ProteinsAnimalsBone and BonesGene Expression Regulation, DevelopmentalHumansMiceMuscle ProteinsPhenotypeMef2ca protein, zebrafishMef2cb protein, zebrafishMEF2 Transcription FactorsMuscle ProteinsZebrafish Proteinsautosomal dominant mental retardation syndrome-20 disease (MRD20)craniofacial developmentMEF2C haploinsufficiency syndromeMef2c mutantsMyocyte enhancer factor 2 (MEF2C)zebrafish (Danio rerio)

Identifiers

PMID37238675
PMCPMC10216501
OpenAlexW4378516884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.